A highly sensitive targeted mass spectrometric assay for quantification of AGR2 protein in human urine and serum. 2014

Tujin Shi, and Yuqian Gao, and Sue Ing Quek, and Thomas L Fillmore, and Carrie D Nicora, and Dian Su, and Rui Zhao, and Jacob Kagan, and Sudhir Srivastava, and Karin D Rodland, and Tao Liu, and Richard D Smith, and Daniel W Chan, and David G Camp, and Alvin Y Liu, and Wei-Jun Qian
Biological Sciences Division, Pacific Northwest National Laboratory , Richland, Washington 99352.

Anterior gradient 2 (AGR2) is a secreted, cancer-associated protein in many types of epithelial cancer cells. We developed a highly sensitive targeted mass spectrometric assay for quantification of AGR2 in urine and serum. Digested peptides from clinical samples were processed by PRISM (high pressure and high resolution separations coupled with intelligent selection and multiplexing), which incorporates high pH reversed-phase liquid chromatography (LC) separations to fractionate and select target fractions for follow-on LC-selected reaction monitoring (LC-SRM) analyses. The PRISM-SRM assay for AGR2 showed a reproducibility of <10% CV and limit of quantification (LOQ) values of ∼130 pg/mL in serum and ∼10 pg per 100 μg of total protein mass in urine, respectively. A good correlation (R(2) = 0.91) was observed for the measurable AGR2 concentrations in urine between SRM and enzyme-linked immunosorbent assay (ELISA). On the basis of an initial cohort of 37 subjects, urinary AGR2/PSA concentration ratios showed a significant difference (P = 0.026) between noncancer and cancer. Large clinical cohort studies are needed for the validation of AGR2 as a useful diagnostic biomarker for prostate cancer. Our work validated the approach of identifying candidate secreted protein biomarkers through genomics and measurement by targeted proteomics, especially for proteins where no immunoassays are available.

UI MeSH Term Description Entries
D008969 Molecular Sequence Data Descriptions of specific amino acid, carbohydrate, or nucleotide sequences which have appeared in the published literature and/or are deposited in and maintained by databanks such as GENBANK, European Molecular Biology Laboratory (EMBL), National Biomedical Research Foundation (NBRF), or other sequence repositories. Sequence Data, Molecular,Molecular Sequencing Data,Data, Molecular Sequence,Data, Molecular Sequencing,Sequencing Data, Molecular
D009088 Mucoproteins Conjugated proteins in which mucopolysaccharides are combined with proteins. The mucopolysaccharide moiety is the predominant group with the protein making up only a small percentage of the total weight.
D011506 Proteins Linear POLYPEPTIDES that are synthesized on RIBOSOMES and may be further modified, crosslinked, cleaved, or assembled into complex proteins with several subunits. The specific sequence of AMINO ACIDS determines the shape the polypeptide will take, during PROTEIN FOLDING, and the function of the protein. Gene Products, Protein,Gene Proteins,Protein,Protein Gene Products,Proteins, Gene
D002138 Calibration Determination, by measurement or comparison with a standard, of the correct value of each scale reading on a meter or other measuring instrument; or determination of the settings of a control device that correspond to particular values of voltage, current, frequency or other output. Calibrations
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D006863 Hydrogen-Ion Concentration The normality of a solution with respect to HYDROGEN ions; H+. It is related to acidity measurements in most cases by pH pH,Concentration, Hydrogen-Ion,Concentrations, Hydrogen-Ion,Hydrogen Ion Concentration,Hydrogen-Ion Concentrations
D000595 Amino Acid Sequence The order of amino acids as they occur in a polypeptide chain. This is referred to as the primary structure of proteins. It is of fundamental importance in determining PROTEIN CONFORMATION. Protein Structure, Primary,Amino Acid Sequences,Sequence, Amino Acid,Sequences, Amino Acid,Primary Protein Structure,Primary Protein Structures,Protein Structures, Primary,Structure, Primary Protein,Structures, Primary Protein
D013058 Mass Spectrometry An analytical method used in determining the identity of a chemical based on its mass using mass analyzers/mass spectrometers. Mass Spectroscopy,Spectrometry, Mass,Spectroscopy, Mass,Spectrum Analysis, Mass,Analysis, Mass Spectrum,Mass Spectrum Analysis,Analyses, Mass Spectrum,Mass Spectrum Analyses,Spectrum Analyses, Mass
D015513 Oncogene Proteins Proteins coded by oncogenes. They include proteins resulting from the fusion of an oncogene and another gene (ONCOGENE PROTEINS, FUSION). Oncogene Products,Oncoprotein,Oncoproteins,Oncogene Product,Oncogene Protein,Product, Oncogene,Products, Oncogene,Protein, Oncogene,Proteins, Oncogene
D056148 Chromatography, Reverse-Phase A chromatography technique in which the stationary phase is composed of a non-polar substance with a polar mobile phase, in contrast to normal-phase chromatography in which the stationary phase is a polar substance with a non-polar mobile phase. Chromatography, Reversed-Phase Liquid,Reversed-Phase Chromatography,Reversed-Phase Liquid Chromatography,Reverse-Phase Chromatography,Reverse-Phase Liquid Chromatography,Chromatography, Reverse Phase,Chromatography, Reversed-Phase,Reverse Phase Chromatography,Reversed Phase Chromatography

Related Publications

Tujin Shi, and Yuqian Gao, and Sue Ing Quek, and Thomas L Fillmore, and Carrie D Nicora, and Dian Su, and Rui Zhao, and Jacob Kagan, and Sudhir Srivastava, and Karin D Rodland, and Tao Liu, and Richard D Smith, and Daniel W Chan, and David G Camp, and Alvin Y Liu, and Wei-Jun Qian
May 2019, Scientific reports,
Tujin Shi, and Yuqian Gao, and Sue Ing Quek, and Thomas L Fillmore, and Carrie D Nicora, and Dian Su, and Rui Zhao, and Jacob Kagan, and Sudhir Srivastava, and Karin D Rodland, and Tao Liu, and Richard D Smith, and Daniel W Chan, and David G Camp, and Alvin Y Liu, and Wei-Jun Qian
November 2007, Journal of chromatography. B, Analytical technologies in the biomedical and life sciences,
Tujin Shi, and Yuqian Gao, and Sue Ing Quek, and Thomas L Fillmore, and Carrie D Nicora, and Dian Su, and Rui Zhao, and Jacob Kagan, and Sudhir Srivastava, and Karin D Rodland, and Tao Liu, and Richard D Smith, and Daniel W Chan, and David G Camp, and Alvin Y Liu, and Wei-Jun Qian
September 2013, The Analyst,
Tujin Shi, and Yuqian Gao, and Sue Ing Quek, and Thomas L Fillmore, and Carrie D Nicora, and Dian Su, and Rui Zhao, and Jacob Kagan, and Sudhir Srivastava, and Karin D Rodland, and Tao Liu, and Richard D Smith, and Daniel W Chan, and David G Camp, and Alvin Y Liu, and Wei-Jun Qian
July 1995, Journal of pharmaceutical and biomedical analysis,
Tujin Shi, and Yuqian Gao, and Sue Ing Quek, and Thomas L Fillmore, and Carrie D Nicora, and Dian Su, and Rui Zhao, and Jacob Kagan, and Sudhir Srivastava, and Karin D Rodland, and Tao Liu, and Richard D Smith, and Daniel W Chan, and David G Camp, and Alvin Y Liu, and Wei-Jun Qian
April 2013, Clinical biochemistry,
Tujin Shi, and Yuqian Gao, and Sue Ing Quek, and Thomas L Fillmore, and Carrie D Nicora, and Dian Su, and Rui Zhao, and Jacob Kagan, and Sudhir Srivastava, and Karin D Rodland, and Tao Liu, and Richard D Smith, and Daniel W Chan, and David G Camp, and Alvin Y Liu, and Wei-Jun Qian
April 2011, Proteome science,
Tujin Shi, and Yuqian Gao, and Sue Ing Quek, and Thomas L Fillmore, and Carrie D Nicora, and Dian Su, and Rui Zhao, and Jacob Kagan, and Sudhir Srivastava, and Karin D Rodland, and Tao Liu, and Richard D Smith, and Daniel W Chan, and David G Camp, and Alvin Y Liu, and Wei-Jun Qian
May 1993, Analytical biochemistry,
Tujin Shi, and Yuqian Gao, and Sue Ing Quek, and Thomas L Fillmore, and Carrie D Nicora, and Dian Su, and Rui Zhao, and Jacob Kagan, and Sudhir Srivastava, and Karin D Rodland, and Tao Liu, and Richard D Smith, and Daniel W Chan, and David G Camp, and Alvin Y Liu, and Wei-Jun Qian
January 2024, Clinical proteomics,
Tujin Shi, and Yuqian Gao, and Sue Ing Quek, and Thomas L Fillmore, and Carrie D Nicora, and Dian Su, and Rui Zhao, and Jacob Kagan, and Sudhir Srivastava, and Karin D Rodland, and Tao Liu, and Richard D Smith, and Daniel W Chan, and David G Camp, and Alvin Y Liu, and Wei-Jun Qian
January 2008, Journal of chromatography. B, Analytical technologies in the biomedical and life sciences,
Tujin Shi, and Yuqian Gao, and Sue Ing Quek, and Thomas L Fillmore, and Carrie D Nicora, and Dian Su, and Rui Zhao, and Jacob Kagan, and Sudhir Srivastava, and Karin D Rodland, and Tao Liu, and Richard D Smith, and Daniel W Chan, and David G Camp, and Alvin Y Liu, and Wei-Jun Qian
January 2017, Journal of biological methods,
Copied contents to your clipboard!